Pfizer says FDA approves arthritis drug Xeljanz

Tuesday, November 6, 2012 - 18:08 in Mathematics & Economics

NEW YORK (AP) -- Pfizer says the Food and Drug Administration approved its rheumatoid arthritis pill Xeljanz (ZEL'jans), seen as potential big seller for the world's largest pharmaceutical company....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net